|
2022
|
Invention
|
Hsd17b13 inhibitors and uses thereof. Described herein are compounds that are HSD17B13 inhibitors... |
|
|
Invention
|
Farnesoid x receptor agonists for the treatment of disease.
Described herein are combination the... |
|
2021
|
Invention
|
Ssao inhibitors for the treatment of disease. Described herein are methods of treatment of diseas... |
|
|
Invention
|
Farnesoid x receptor agonists for the treatment of disease. Described herein is the use of farnes... |
|
|
Invention
|
Crystalline forms of a farnesoid x receptor agonist. Described herein is the farnesoid X receptor... |
|
|
Invention
|
Formulations of a farnesoid x receptor agonist. Described herein are pharmaceutical formulations ... |
|
2019
|
Invention
|
Ssao inhibitors and uses thereof.
Described herein are compounds that are semicarbazide-sensitiv... |
|
|
Invention
|
Ssao inhibitors and uses thereof. Described herein are compounds that are semicarbazide-sensitive... |
|
|
Invention
|
Farnesoid x receptor agonists and uses thereof.
Described herein are compounds that are farnesoi... |
|
|
Invention
|
Crystalline forms of a farnesoid x receptor agonist.
Described herein is the farnesoid X recepto... |
|
|
Invention
|
Farnesoid x receptor agonists and uses thereof. Described herein are compounds that are farnesoid... |
|
|
Invention
|
Farnesoid x receptor agonists for the treatment of disease. Described herein are combination ther... |
|
|
Invention
|
Crystalline forms of a farnesoid x receptor agonist. trans-NHNtranstrans-4-(4-methoxy-3-methyl ph... |
|
|
P/S
|
Pharmaceuticals. Pharmaceutical research and development; pharmaceutical products development; re... |
|
2018
|
P/S
|
pharmaceutical research and development; pharmaceutical products development; research and develo... |
|
2017
|
Invention
|
Methods of treating lipodystrophy using fgf-1 compounds.
Provided herein are methods and composi... |
|
|
Invention
|
Fgf mutants and uses thereof. Disclosed herein are FGF compositions and methods of treating a met... |
|
2016
|
Invention
|
Farnesoid x receptor agonists and uses thereof.
Described herein are compounds that are famesoid... |
